PTC
RXDX

Private Trust Company’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Private Trust Company’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-37
Closed -$3.97K – 2388
2023
Q1 		$3.97K Hold
37
– – ﹤0.01% 1923
2022
Q4 		$4K Buy
+37
New +$4K ﹤0.01% 1907